<VariationArchive RecordType="classified" VariationID="375635" VariationName="NG_009873.1:g.(?_5000)_(160068_?)del" VariationType="Deletion" Accession="VCV000375635" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2017-02-17" MostRecentSubmission="2017-02-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="362447" VariationID="375635">
      <GeneList>
        <Gene Symbol="LOC130058355" FullName="ATAC-STARR-seq lymphoblastoid active region 10335" GeneID="130058355" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3787986" stop="3788285" display_start="3787986" display_stop="3788285" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058356" FullName="ATAC-STARR-seq lymphoblastoid silent region 7140" GeneID="130058356" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3879702" stop="3879751" display_start="3879702" display_stop="3879751" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="CREBBP" FullName="CREB binding protein" GeneID="1387" HGNC_ID="HGNC:2348" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3725054" stop="3880713" display_start="3725054" display_stop="3880713" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3775054" stop="3930120" display_start="3775054" display_stop="3930120" Strand="-" />
          </Location>
          <OMIM>600140</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CREBBP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CREBBP">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC125146381" FullName="Sharpr-MPRA regulatory region 6998" GeneID="125146381" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3871208" stop="3871502" display_start="3871208" display_stop="3871502" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC125146382" FullName="Sharpr-MPRA regulatory region 1734" GeneID="125146382" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3872039" stop="3872702" display_start="3872039" display_stop="3872702" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058353" FullName="ATAC-STARR-seq lymphoblastoid active region 10333" GeneID="130058353" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3780811" stop="3780870" display_start="3780811" display_stop="3780870" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058354" FullName="ATAC-STARR-seq lymphoblastoid active region 10334" GeneID="130058354" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3787856" stop="3787915" display_start="3787856" display_stop="3787915" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058357" FullName="ATAC-STARR-seq lymphoblastoid silent region 7141" GeneID="130058357" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3879832" stop="3879881" display_start="3879832" display_stop="3879881" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058358" FullName="ATAC-STARR-seq lymphoblastoid silent region 7142" GeneID="130058358" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3879922" stop="3880231" display_start="3879922" display_stop="3880231" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NG_009873.1:g.(?_5000)_(160068_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" innerStart="3725053" innerStop="3880121" display_start="3725053" display_stop="3880121" variantLength="155069" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="3775054" innerStop="3930122" display_start="3775054" display_stop="3930122" variantLength="155069" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(?_3725053)_(3880121_?)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(?_3725053)_(3880121_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_3775054)_(3930122_?)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_3775054)_(3930122_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009873.1" sequenceAccession="NG_009873" sequenceVersion="1" change="g.(?_5000)_(160068_?)del">
            <Expression>NG_009873.1:g.(?_5000)_(160068_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_009873.1:g.(?_5000)_(160068_?)del AND Rubinstein-Taybi syndrome due to CREBBP mutations" Accession="RCV000417106" Version="1">
        <ClassifiedConditionList TraitSetID="1898">
          <ClassifiedCondition DB="MedGen" ID="C4551859">Rubinstein-Taybi syndrome due to CREBBP mutations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-11-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-11-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-02-17" MostRecentSubmission="2017-02-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26486927</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1898" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4360" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Rubinstein-Taybi syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RUBINSTEIN-TAYBI SYNDROME 1, INCOMPLETE</ElementValue>
                <XRef Type="Allelic variant" ID="600140.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600140.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rubinstein syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Broad thumbs and great toes, characteristic facies, and mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rubinstein-Taybi syndrome due to CREBBP mutations</ElementValue>
                <XRef ID="MONDO:0008393" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CREBBP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RSTS1</ElementValue>
                <XRef Type="MIM" ID="180849" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RTS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CREBBP-Related Rubinstein-Taybi Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17534" />
                <XRef ID="17534" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Rubinstein-Taybi syndrome (RSTS) is characterized by distinctive facial features, broad and often angulated thumbs and halluces, short stature, and moderate-to-severe intellectual disability. The characteristic craniofacial features are downslanted palpebral fissures, low-hanging columella, high palate, grimacing smile, and talon cusps. Prenatal growth is often normal, then height, weight, and head circumference percentiles rapidly drop in the first few months of life. Short stature is typical in adulthood. Obesity may develop in childhood or adolescence. Average IQ ranges between 35 and 50; however, developmental outcome varies considerably. Some individuals with EP300-RSTS have normal intellect. Additional features include ocular abnormalities, hearing loss, respiratory difficulties, congenital heart defects, renal abnormalities, cryptorchidism, feeding problems, recurrent infections, and severe constipation.</Attribute>
                <XRef ID="NBK1526" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301699</ID>
                <ID Source="BookShelf">NBK1526</ID>
              </Citation>
              <XRef ID="353277" DB="Orphanet" />
              <XRef ID="783" DB="Orphanet" />
              <XRef ID="C4551859" DB="MedGen" />
              <XRef ID="MONDO:0008393" DB="MONDO" />
              <XRef Type="MIM" ID="180849" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="967829" SubmissionDate="2016-03-18" DateLastUpdated="2017-02-17" DateCreated="2017-02-17">
        <ClinVarSubmissionID localKey="8_March2016|OMIM:180849" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000494652" DateUpdated="2017-02-17" DateCreated="2017-02-17" Type="SCV" Version="1" SubmitterName="Center of Genomic medicine, Geneva, University Hospital of Geneva" OrgID="505593" OrganizationCategory="laboratory" OrgAbbreviation="GenMed_GVA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26486927</ID>
          </Citation>
          <Comment Type="public">Patient with Rubinstein-Taybi syndrome, and with a complete heterozygous deletion of the CREBBP gene.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="Pubmed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CREBBP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.[0];[=]</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NG_009873.1:g.(?_5000)_(160068_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180849" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyDescription>FinalReportsDec_March2016</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>March2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="967829" TraitType="Disease" MappingType="XRef" MappingValue="180849" MappingRef="OMIM">
        <MedGen CUI="C4551859" Name="Rubinstein-Taybi syndrome due to CREBBP mutations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

